TCDD-inducible plasminogen activator inhibitor type 2 (PAI-2) in human hepatocytes, HepG2 and monocytic U937 cells

Carcinogenesis

Volumn 17, Issue 3, 1996, Pages 443-449

  Gohl, G ^a   Lehmkoster T ^a   Munzel P A ^a   Schrenk, D ^a   Viebahn, R ^a   Bock, K W ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PLASMINOGEN ACTIVATOR INHIBITOR 2;

ARTICLE; CONTROLLED STUDY; GENE INDUCTION; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CELL; MONOCYTE; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL; PROTEIN INDUCTION;

ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; CARCINOMA, HEPATOCELLULAR; CYTOCHROME P-450 ENZYME SYSTEM; DACTINOMYCIN; DNA-BINDING PROTEINS; HUMANS; LIVER; LIVER NEOPLASMS; PLASMINOGEN ACTIVATOR INHIBITOR 2; PROTEIN SYNTHESIS INHIBITORS; RECEPTORS, ARYL HYDROCARBON; RNA, MESSENGER; SERINE PROTEINASE INHIBITORS; TETRACHLORODIBENZODIOXIN; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0029919538     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.3.443     Document Type: Article

References (49)

1. Suner,T.R., Guzman,K., Dold,K.M. and Greenlee,W.F. (1991) Targets for Dioxin: Genes for plasminogen activator inhibitor-2 and interleukin-1β Science, 245, 415.
2. Sutter,T.R. and Greenlee,W.F. (1992) Classification of members of the Ah gene battery. Chemosphere, 25, 223-226.
3. Poland,A. and Knutson,J.C. (1982) 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated hydrocarbons: examination of the mechanism of toxicity. Annu Rev. Pharmacol. Toxicol., 22, 517-554.
4. Whitlock,J.P. (1990) Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p-dioxin action. Annu. Rev. Pharmacol. Toxicol., 30, 251-277.
5. Bock,K.W. (1993) Aryl hydrocarbon or dioxin receptor: biologic and toxic responses. Rev. Physiol. Biochem. Pharmacol., 125, 1-42.
6. Burbach,K.M., Poland,A. and Bradfield,C.A. (1992) Cloning of the Ahreceptor cDNA reveals a distinctive ligand-activated transcription factor. Proc. Natl Acad. Sci. USA, 89, 8185-8189.
7. Ema,M., Sogawa,K., Watanabe,N., Chujoh,Y., Matsushita,N., Gotoh,I., Funae,Y. and Fujii-Kuriyama,Y. (1992) cDNA cloning and structure of mouse putative Ah receptor. Biochem. Biophys. Res. Commun., 184, 246-253.
8. Poellinger,L., Göttlicher,M. and Gustafsson,J.-A. (1992) The dioxin and peroxisome proliferator-activated receptors: nuclear receptors in search of endogenous ligands. Trends Pharmacol. Sci., 13. 241-245.
9. Okey,A.B., Riddick,D.S. and Harper,P.A. (1994) Molecular biology of the aromatic hydrocarbon (dioxin) receptor. Trends Pharmacol. Sci., 15, 226-232.
10. Ye,R.D., Wun,T,-C. and Sadler,J.E. (1987) cDNA cloning and expression in Escherichia coli of a plasminogen activator inhibitor from human placenta. J. Biol. Chem., 262, 3718-3725.
11. Blasi,F., Vassalli,J.-D. and Dano,K. (1987) Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors. J. Cell Biol., 104, 801-804.
12. Laiho,M. and Keski-Oja,J. (1989) Growth factors in the regulation of pericellular proteolysis: a review. Cancer Res.. 49, 2533-2553.
13. a. Transglutaminase-catalyzed cross-linking to cellular and extracellular structures. Eur. J. Biochem., 214, 141-146.
14. Kociba,R.J., Keyes,D.G., Beyer,J.E. et al. (1978) Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol. Appl. Pharmacol., 46, 279-303.
15. Huff,J., Lucier,G. and Tritscher,A. (1994) Carcinogenicity of TCDD: experimental, mechanistic, and epidemiologic evidence. Annu. Rev. Pharmacol. Toxicol., 34, 343-372.
16. Schleuning,W.-D., Medcalf,R.L., Hession,C., Rothenbühler,R., Shaw,A. and Kruithof,E.K.O. (1987) Plasminogen activator inhibitor 2: regulation of gene transcription during phorbol ester-mediated differentiation of U-937 human histiocytic lymphoma cells. Mol. Cell. Biol., 7, 4564-4567.
17. Schwartz.,B.S. and Bradshaw,J.D. (1992) Regulation of plasminogen activator inhibitor mRNA levels in lipopolysaccharide-stimulated human monocytes. J. Biol. Chem., 267, 7089-7094.
18. Angel,P. and Karin,M. (1991) The role of Jun, Fos and the AP-I complex in cell-proliferation and transformation. Biochim. Biophys. Acta, 1072, 129-157
19. Meek,D.W. and Street,A. (1992) Nuclear protein phosphorylation and growth control. Biochem. J., 287, 1-15.
20. Medcalf,R.L. (1992) Cell- and gene-specific interactions between signal transduction pathways revealed by okadaic acid. J. Biol. Chem., 267, 12220-12226.
21. Kruithof,E.K.O. and Cousin,E. (1988) Plasminogen activator inhibitor 2 Isolation and characterization of the promoter region of the gene. Biochem. Biophys. Res. Commun., 156, 383-388.
22. Cousin,E., Medcalf,R.L., Bergonzelli,G.E. and Kruithof,E.K.O. (1991) Regulatory elements involved in constitutive and phorbol ester-inducible expression of the plasminogen activator inhibitor type 2 gene promoter. Nucleic Acids Res., 19, 3881-3886.
23. Schrenk,D., Stüven,T., Gohl,G., Viebahn,R. and Bock,K.W, (1995) Induction of CYP1A and glutathione S-transferase activities by 2,3,7,8-tetrachlorodibenzo-p-dioxin in human hepatocyte cultures. Carcinogenesis, 16, 943-946.
24. Chomczynski,P. and Sacchi,N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol- chloroform extraction. Anal. Biochem., 162, 156-159.
25. Chirgwin,J.M., Przybyla,A.E., MacDonald,R.J and Rutter.WJ. (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18, 5294-5299.
26. Bantle,J.A., Maxwell,I.H. and Hahn,W.E. (1976) Specificity of oligo (dT)-cellulose chromatography in the isolation of polyadenylated RNA. Anal. Biochem., 72, 413-427.
27. Gonzalez,F.J., Mackenzie,P.I., Kimura,S. and Nebert,D W (1984) Isolation and characterization of full-length mouse cDNA and genomic clones of 3-methylcholanthrene-inducible cytochrome PI-450 and P3-450. Gene, 29, 281-292.
28. Angel,P., Allegretto,E.A., Okino,S.T., Hattori,K., Boyle,W.J., Hunter,T. and Karin,M. (1988) Oncogene jun encodes a sequence-specific transactivator similar to AP-I. Nature. 332. 166-171.
29. Curran,T., Peters,G., Van Beveren,C., Teich,N.M. and Verma,I.M. (1982) FBJ murine osteosarcoma virus, identification and molecular cloning of biologically active proviral DNA. J. Virol.. 44, 674-682
30. Ryder,K., Lau,L.F. and Nathans,D. (1988) A gene activated by growth factors is related to the oncogene v-jun. Proc. Natl Acad. Sci. USA, 85, 1487-1491.
31. Ryder,K., Lanahan,A., Perez-Albueme,E. and Nathans,D. (1989) jun-D: a third member of the jun gene family. Proc. Natl Acad. Sci. USA, 86, 1500-1503.
32. Mason,G.G.F., Witte,A.-M., Whitelaw,M.L., Antonsson,C., McGuire,J., Wilhelmsson,A., Poellinger,L. and Gustafsson,J.-A. (1994) Purification of the DNA binding form of dioxin receptor. Role of the ARNT cofactor in regulation of dioxin receptor function. J. Biol. Chem., 269, 4438-449.
33. Fort,P., Marty,L., Piechaezyl,M., Sabrouty,S.E., Dani,C., Jeanteur,P. and Blanchard,J.M. (1985) Various rat tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res., 13, 1431-1443.
34. Feinberg,A.P. and Vogelstein,B. (1983) A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem.. 132, 6-13.
35. Laemmli,U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature. 227, 680-685.
36. Whitlock,J.P.,Jr. and Galeazzi,D.R. (1984) 2,3,7,8-Tetrachlorodibenzo-p-dioxin receptors in wild type and variant mouse hepatoma cells. J. Biol. Chem., 259, 980-985.
37. Dolwick,K.M., Schmidt,J.V., Carver,L.A., Swanson,H.I. and Bradfield,C.A. (1993) Cloning and expression of a human Ah receptor cDNA. Mol. Pharmacol., 44, 911-917.
38. Hoffman,E.C., Reyes,H., Chu,F.-F., Sander.F., Conley,L.H., Brooks,B.A. and Hankinson,O. (1991) Cloning of a factor required for activity of the Ah (dioxin) receptor. Science, 252, 954-958.
39. Pollenz,R.S., Sattler,C.A. and Poland,A. (1994) The aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein show distinct subcellular localizations in Hepa Iclc7 cells by immunofluorescence microscopy. Mol. Pharmacol., 45, 428-438.
40. Munzel,P.A., Brück,M. and Bock, K.W. (1994) Tissue-specific constitutive and inducible expression of rat phenol UDP-glucuronosyltransferase. Biochem. Pharmacol., 47, 1445-1448.
41. Hayashi,S.-I., Okabe-Kado,J., Honma,Y. and Kawajiri,K. (1995) Expression of Ah receptor (TCDD receptor) during human monocytic differentiation. Carcinogenesis, 16, 1403-1409.
42. Gross,J.L., Krupp,M.N., Rifkin,D.B. and Lane,M.D. (1983) Downregulation of epidermal growth factor receptor correlates with plasminogen activator activity in human A431 epidermoid carcinoma cells. Proc Natl Acad Sci. USA, 80, 2276-2280.
43. Greenlee,W.F., Sutter,T.R. and Marcus,C. (1994) Molecular basis of dioxin actions on rodent and human target tissues. Prog Clin. Biol. Res., 387, 47-57.
44. Schäfer,S., Zerbe,O. and Gressner,A. (1987) The synthesis of proteoglycans in fat-storing cells of rat liver. Hepatology, 7, 680-687.
45. Vanden Heuvel,J.P., Clark,G.C., Kohn,M C., Tritscher,A M., Greenlee,W.F., Lucier,G.W. and Bell,D.A. (1994) Dioxin-responsive genes: examination of dose-response relationships using quantitative reverse transcriptasepolymerase chain reaction. Cancer Res., 54, 62-68.
46. 2 expression in a human keratinocyte cell line involves both transcriptional and post-transcriptional control. J. Biol. Chem., 267, 24591-24595.
47. Puga,A., Nebert,D.W. and Carrier,F. (1992) Dioxin induces expression of c-fos and c-jun proto-oncogenes and a large increase in transcription factor AP-1. DNA Cell Biol., 11, 269-281.
48. Cohen,R.L., Niclas,J., Lee,W M.F., Wun,T.-C., Crowley,C.W., Levinson, A.D., SadlerJ.E. and Shuman,M.A. (1989) Effects of cellular transformation on expression of plasminogen activator inhibitors 1 and 2. J. Biol. Chem., 264, 8375-8383.
49. Ganesh,S., Sier,C.F.M., Griffioen,G. et al. (1994) Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer. Cancer Res.. 54, 4065-4071.